Pharma giant says will soon seek authorization for the medication's use; if cleared, would be 1st pill shown to treat those infected with virus, a potentially major advance

UN organization claims the medicine, which has received approval as a coronavirus treatment from several health agencies, has 'no important effect' on improving survival chances

Medicine found to cut recovery time by five days on average, but no studies have shown it improves chances of surviving the coronavirus

6-month trial finds drug used to treat Trump, listed as standard care in US, had 'little or no effect' on if patients die within a month or whether hospitalized patients recovered

US president gets anti-viral after earlier receiving experimental treatment; tweets from medical facility that it is 'going well, I think'; campaign manager tests positive

Top health official also announces development of cheaper version of remdesivir and favipiravir, which are believed to be helpful in treating some serious COVID-19 cases

Just as treatment wows some Israeli doctors, country’s stocks are dwindling; at least two hospitals can't get it; in Haifa, a patient in serious condition has his supply halted

Ironically, attempts to fast-track research on COVID-19 drugs have led to a slew of low-quality studies that add to confusion. And statements by politicians aren't helping either

Bloc's health chief calls approval of drug, which studies have shown can reduce hospital stays for COVID-19 patients, 'an important step forward in the fight against this virus'

Government backs Health Ministry in authorizing Gilead Sciences' donation of medicine

Pages